Warren Buffett's Berkshire invests in four Big Pharma companies

What led Warren Buffett to change his mind on gold?

Divine Capital CEO Dani Hughes and Heritage Capital’s Paul Schatz analyze Warren Buffett investing in gold, the rise of day trading apps like Robinhood and economic and market recovery.

Through his Berkshire Hathaway Inc., Warren Buffett invested in four Big Pharma companies in the third quarter, according to Berkshire's 13F filing.

Continue Reading Below

More than $1.8 billion was put in AbbVie (21.2M shares), Bristol Myers Squibb (30M shares), and Merck (22.4M shares), as well as $136 million in Pfizer (3.71M shares).

TickerSecurityLastChangeChange %
ABBVABBVIE INC.98.44-0.56-0.57%
BMYBRISTOL-MYERS SQUIBB CO.64.50+0.88+1.38%
MRKMERCK & CO. INC.80.18-0.91-1.12%
PFEPFIZER INC.37.33-1.29-3.34%

Berkshire also made a $250 million investment in the initial public offering for the data-warehousing company Snowflake Inc.

CLICK HERE TO READ MORE ON FOX BUSINESS

TickerSecurityLastChangeChange %
SNOWSNOWFLAKE INC.241.85+7.05+3.00%

But none of these 2020 investments had risen to the "elephant" scale, Buffett's term for a big buy, relative to the conglomerate's size and available cash.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Berkshire owns more than 90 companies, including Geico insurance and utility, furniture, manufacturing, and jewelry businesses.

The Omaha, Nebraska-based conglomerate also has major investments in such companies as American Express, Moody’s and Coca-Cola.

Source: Read Full Article

Copyright © All rights reserved. | CoverNews by AF themes.